We also found that in 2 month-old infants, levels of PT IgG elicited by recombinant pertussis formulations were higher than non-recombinant Tdap comparator, Tdap8 chem, which has been shown to be effective in reducing neonatal pertussis in observational studies [5]. The gene discussed is F2; the disease is pertussis.